본문 바로가기
KERD
논문KCI 등재

네트워크 약리학을 이용한 소양증을 동반한 피부 염증에 대한 枳實의 잠재적 치료기전 탐색

Analysis of Potential Active Ingredients and Treatment Mechanism of Ponciri Fructus Immaturus for Dermatitis Accompanied by Pruritus Using Network Pharmacology

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives : To identify the active ingredient of Poncirus Trifoliata Immaturus and to explore the mechanism expected to potentially act on dermatitis accompanied by pruritus. Methods : We conducted the network pharmacological analysis. We selected effective ingredients among the active compounds of Poinciri Fructus Immaturus. We found the target protein of the selected active ingredient, disease(dermatitis accompanied by pruritus) and fexofenadine. Then we established the network between the proteins which Poinciri Fructus Immaturus and fexofenadine intersected with disease respectively, and the coregene was also extracted. After that, the active pathways in the human body involving the groups and coregenes were searched. Results : Total of 7 active ingredients were selected, and 202 target proteins were collected. There were 756 proteins related to inflammatory skin disease accompanied by pruritus, and 75 proteins were related to fexofenadine. 42 proteins crossed by Poinciri Fructus Immaturus with a disease, and 31 proteins crossed by fexofenadine with a disease. 12 proteins were found as a coregene from the proteins that cross Poinciri Fructus Immaturus and disease. Coregenes are involved in ‘Nitric-oxide synthase regulator activity’, ‘Epidermal growth factor receptor signaling pathway’. 2 groups that extracted are invloved in ‘Fc receptor signaling pathway’, ‘Central carbon metabolism in cancer’, ‘Phosphatidylinositol 3-kinase complex, class IB’, and ‘omega-hydroxylase P450 pathway’. Conclusion : It is expected that Poinciri Fructus Immaturus will be able to show direct or indirect anti-pruritus and anti-inflammatory effects on skin inflammation accompanied by pruritus in the future. And it is also expected to have a synergy effect with fexofenadine on skin disease.

Abstract

Objectives : To identify the active ingredient of Poncirus Trifoliata Immaturus and to explore the mechanism expected to potentially act on dermatitis accompanied by pruritus. Methods : We conducted the network pharmacological analysis. We selected effective ingredients among the active compounds of Poinciri Fructus Immaturus. We found the target protein of the selected active ingredient, disease(dermatitis accompanied by pruritus) and fexofenadine. Then we established the network between the proteins which Poinciri Fructus Immaturus and fexofenadine intersected with disease respectively, and the coregene was also extracted. After that, the active pathways in the human body involving the groups and coregenes were searched. Results : Total of 7 active ingredients were selected, and 202 target proteins were collected. There were 756 proteins related to inflammatory skin disease accompanied by pruritus, and 75 proteins were related to fexofenadine. 42 proteins crossed by Poinciri Fructus Immaturus with a disease, and 31 proteins crossed by fexofenadine with a disease. 12 proteins were found as a coregene from the proteins that cross Poinciri Fructus Immaturus and disease. Coregenes are involved in ‘Nitric-oxide synthase regulator activity’, ‘Epidermal growth factor receptor signaling pathway’. 2 groups that extracted are invloved in ‘Fc receptor signaling pathway’, ‘Central carbon metabolism in cancer’, ‘Phosphatidylinositol 3-kinase complex, class IB’, and ‘omega-hydroxylase P450 pathway’. Conclusion : It is expected that Poinciri Fructus Immaturus will be able to show direct or indirect anti-pruritus and anti-inflammatory effects on skin inflammation accompanied by pruritus in the future. And it is also expected to have a synergy effect with fexofenadine on skin disease.

참고문헌 (40)

  1. 정민재, "가려움증의 병태생리 및 최신치료", 대한의사협회지, 61(11), pp.670~677 (2018), 대한의사협회[DOI]
  2. Millington GWM, "British Association of Dermatologists’ guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018", Br J Dermatol, 178(1), pp.34~60 (2018)
  3. Weisshaar E, "European S2k Guideline on Chronic Pruritus", Acta Derm Venereol, 99(5), pp.469~506 (2019)
  4. Zhang R, "Network pharmacology databases for traditional Chinese medicine : Review and assessment", Front Pharmacol, 10, pp.1~14 (2019)
  5. Luo T, "Network Pharmacology in Research of Chinese Medicine Formula : Methodology, Application and Prospective", Chin J Integr Med, 26(1), pp.72~80 (2020)
  6. Korea Institute of Oreintal Medicine, "Jisil(枳實)A", pp.1~5 (2007), Kor Intellectual Property Office
  7. Cha KJ, "Poncirus trifoliata (L.) raf. extract inhibits the development of atopic dermatitislike lesions in human keratinocytes and NC", Nga mice, 2019, pp.16(8), 1116~1122
  8. Song Y, "Systemic elucidation on the potential bioactive compounds and hypoglycemic mechanism of Polygonum multiflorum based on network pharmacology", Chinese Med(United Kingdom), 15(1), pp.1~15 (2020)
  9. Xu X, "A novel chemometric method for the prediction of human oral bioavailability", Int J Mol Sci, 13(6), pp.6964~6982 (2012)
  10. Ding S, "Based on Network Pharmacology and Molecular Docking to Explore the Underlying Mechanism of Huangqi Gegen Decoction for Treating Diabetic Nephropathy", Evidencebased Complement Altern Med, pp.1~16 (2021)
  11. Fang Y, "Network Pharmacology Analysis of Traditional Chinese Medicine Formula Shuang Di Shou Zhen Tablets Treating Nonexudative Age-Related Macular Degeneration", Evidence-based Complement Altern Med, pp.1~14 (2021)
  12. Lu Y, "Identification of differentially expressed genes and signaling pathways using bioinformatics in interstitial lung disease due to tyrosine kinase inhibitors targeting the epidermal growth factor receptor", Invest New Drugs, 37(2), pp.384~400 (2019)
  13. Vella D, "MTGO : PPI Network Analysis Via Topological and Functional Module Identification", Sci Rep, 8(1), pp.1~13 (2018)
  14. Yin B, "Molecular mechanism of the effect of Huanglian Jiedu decoction on type 2 diabetes mellitus based on network pharmacology and molecular docking", J Diabetes Res (2020)
  15. Moradifard S, "Analysis of microRNA and Gene Expression Profiles in Alzheimer’s Disease : A Meta-Analysis Approach", Sci Rep, 8(1), pp.1~17 (2018)
  16. 안윤혜, "만성 가려움의 병태생리와 감별 진단 및 치료", Allergy Asthma & Respiratory Disease, 9(4), pp.189~202 (2021), 대한 소아알레르기 호흡기학회[DOI]
  17. Pereira MP, "Challenges in clinical research and care in pruritus", Acta Derm Venereol, 100(2), pp.45~51 (2020)
  18. Wang X, "Anti-inflammatory effects of polymethoxyflavones from citrus peels : a review", J Food Bioact, 3, pp.76~86 (2018)
  19. Okabe Y, "Suppression of adipocyte hypertrophy by polymethoxyflavonoids isolated from Kaempferia parviflora", Phytomedicine, 21(6), pp.800~806 (2014)
  20. Sae-Wong C, "Suppressive effects of methoxyflavonoids isolated from Kaempferia parviflora on inducible nitric oxide synthase (iNOS)expression in RAW 264.7 cells", J Ethnopharmacol, 136(3), pp.488~495 (2011)
  21. Cole C, "Nitric Oxide Increases Susceptibility of Toll-like Receptor-Activated Macrophages to Spreading Listeria monocytogenes", Immunity, 36(5), pp.807~820 (2012)
  22. Stojanović I, "Nitric oxide-mediated signalization and nitrosative stress in neuropathology", J Med Biochem, 31(4), pp.295~300 (2012)
  23. Szelest M, "A new insight into the potential role of tryptophan-derived ahr ligands in skin physiological and pathological processes", Int J Mol Sci, 22(3), pp.1~31 (2021)
  24. Lai ZZ, "Cyclooxygenase-2 in endometriosis", Int J Biol Sci, 15(13), pp.2783~2797 (2019)
  25. Ramot Y, "The role of PPARγ-mediated signalling in skin biology and pathology : New targets and opportunities for clinical dermatology", Exp Dermatol, 24(4), pp.245~251 (2015)
  26. Lennartsson J, "Stem cell factor receptor", c-Kit : From basic Science to clinical implications, 2012, pp.92(4), 1619~1649
  27. Andoh T, "Nitric oxide enhances substance P-induced itch-associated responses in mice", Br J Pharmacol, 138(1), pp.202~208 (2003)
  28. Haddadi NS, "Possible Involvement of Nitric Oxide in the Antipruritic Effect of Metformin on Chloroquine-Induced Scratching in Mice", Dermatology, 236(2), pp.151~159 (2020)
  29. Choi JE, "Skin neurogenic inflammation", Semin Immunopathol, 40(3), pp.249~259 (2018)
  30. Peus D, "EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation", J Invest Dermatol, 109(6), pp.751~756 (1997)
  31. Joly-Tonetti N, "EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function", BMC Cancer, 21(1), pp.1~10 (2021)
  32. Liu F, "Neuronal Fc-epsilon receptor I contributes to antigen-evoked pruritus in a murine model of ocular allergy", Brain Behav Immun, 61, pp.165~175 (2017)
  33. Kanagaratham C, "IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy", Front Immunol, 11, pp.1~22 (2020)
  34. Liu J, "Role of the IgM Fc receptor in immunity and tolerance", Front Immunol, 10, pp.1~9 (2019)
  35. Chen X, "Radioisotope-Based Protocol for Determination of Central Carbon Metabolism in T Cells", T-Cell Recept Signal, 2111, pp.257~265 (2020)
  36. Mercurio L, "Recent Updates on the Involvement of PI3K", AKT, Front Med, pp.2021, 8[DOI]
  37. Wang J, "Hypoxia adipose stem cell-derived exosomes promote high-quality healing of diabetic wound involves activation of PI3K", Akt pathways, 2021, pp.19(1), 1~13
  38. Ohno Y, "Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation", Proc Natl Acad Sci U S A, 112(25), pp.7707~7712 (2015)
  39. Wu H, "Estrogen Acts Through Estrogen Receptor-β to Promote Mannan-Induced Psoriasis-Like Skin Inflammation", Front Immunol, 13, pp.1~15 (2022)
  40. Humbert M, "Pathology and pathobiology of pulmonary hypertension : State of the art and research perspectives", Eur Respir J, 53(1), pp.1~14 (2019)

관련 논문AI추천

네트워크 약리학을 이용한 소양증을 동반한 피부 염증에 대한 陳皮의 잠재적 치료기전 탐색김규석, 김병현, 김윤범, 남혜정, 이은경, 이희재, 홍예은대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2025 · 제38권 제1호네트워크 약리학을 이용한 소양증을 동반한 피부 염증에 대한 蒼朮 및 厚朴의 잠재적 치료기전 탐색김규석, 김병현, 김윤범, 남혜정, 서광일, 홍예은대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2023 · 제36권 제4호네트워크 약리학을 활용한 심상성 건선에 대한 澤瀉의 잠재적 작용 기전 탐색 연구김규석, 김윤범, 남혜정, 박수진, 이은경, 이희재, 홍예은대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2025 · 제38권 제3호아토피 피부염에 대한 인진호 추출물의 네트워크 약리학 분석 및 효능김대용, 김미혜대한미용학회 · 대한미용학회지2024 · 제20권 제3호네트워크 약리학적 방법론을 활용한 한의학 효능 연구 고찰권영규, 백종민, 서한길한의병리학회 · 동의생리병리학회지2016 · 제30권 제6호네트워크 약리학을 활용한 심상성 건선에 대한 茵蔯蒿의 잠재적 작용 기전 탐색 연구김규석, 김병현, 김윤범, 김준동, 서광일, 이한림대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2022 · 제35권 제3호

이 간행물의 다른 논문 (15건)